Clinical Trials Browser

Phase NA × Suspended × Lymphoma, Non-Hodgkin × Clear all

NCT03229876 2023-07-24

Safety and Efficacy Evaluation of CD19-UCART

Phase NA Suspended

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma